Hired someone new and exciting? Promoted a rising star? Finally solved that hard-to-fill spot? Share the news with us, and we’ll share it with others. That’s right. Send us your changes, and we’ll find a home for them. Don’t be shy. Everyone wants to know who is coming and going.
And here is our regular feature in which we highlight a different person each week. This time around, we note that Sangamo Therapeutics (SGMO) hired D. Mark McClung as executive vice president and chief business officer. Most recently, he worked as a consultant and, before that, was vice president and general manager of global oncology commercial at Amgen (AMGN).